AstraZeneca Sues to Block Top Dealmaker Sharing Therapy Data With GSK

Sheldon, who was one of AstraZeneca’s most senior employees, is set to start at GSK in September. The executive had access to confidential information in a whole host of sensitive areas including the firm’s cancer work, AstraZeneca said in a legal filing. He was paid more than £644,000 ($774,090) in shares in 2021 to sign the non-compete clause.

Source link